GluN2D-containing NMDA receptors in parvalbumin neurons in the nucleus accumbens regulate nocifensive responses in neuropathic painNEUROBIOLOGY OF DISEASEIF5.62025-02-010OAAI
Local delivery of soluble fractalkine (CX3CL1) peptide restores ribbon synapses after noise-induced cochlear synaptopathyFRONTIERS IN CELLULAR NEUROSCIENCEIF42024-10-300OAAI
Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disordersJOURNAL OF EXTRACELLULAR VESICLESIF14.52024-04-223OA
GluN2D Subunit in Parvalbumin Interneurons Regulates Prefrontal Cortex Feedforward Inhibitory Circuit and Molecular Networks Relevant to SchizophreniaBIOLOGICAL PSYCHIATRYIF92023-08-0112OAAI
GluN2D subunit-containing NMDA receptors regulate reticular thalamic neuron function and seizure susceptibility*NEUROBIOLOGY OF DISEASEIF5.62023-06-013OAAI
Achyranthes aspera ameliorates stress induced depression in mice by regulating neuroinflammatory cytokinesJOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINEIF32022-11-014OAAI
Glutamate delta 1 receptor regulates autophagy mechanisms and affects excitatory synapse maturation in the somatosensory cortexPHARMACOLOGICAL RESEARCHIF10.52022-04-0110OAAI
Dysfunction of Glutamate Delta-1 Receptor-Cerebellin 1 Trans-Synaptic Signaling in the Central Amygdala in Chronic PainCELLSIF5.22021-10-0312OAAI
Facilitation of GluN2C-containing NMDA receptors in the external globus pallidus increases firing of fast spiking neurons and improves motor function in a hemiparkinsonian mouse modelNEUROBIOLOGY OF DISEASEIF5.62021-03-0119OAAI
Striatal glutamate delta-1 receptor regulates behavioral flexibility and thalamostriatal connectivityNEUROBIOLOGY OF DISEASEIF5.62020-04-0126OAAI
Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypesSCIENTIFIC REPORTSIF3.92019-05-2026OAAI
Acute orexigenic effect of agmatine involves interaction between central α2-adrenergic and GABAergic receptorsBIOMEDICINE & PHARMACOTHERAPYIF7.52017-09-018PREAI
Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animalsBIOMEDICINE & PHARMACOTHERAPYIF7.52017-08-0125PREAI
Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in ratsBIOMEDICINE & PHARMACOTHERAPYIF7.52017-02-0137PREAI
Pharmacological validation of in-silico guided novel nootropic potential of Achyranthes aspera L.JOURNAL OF ETHNOPHARMACOLOGYIF5.42015-12-0125PREAI
Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in ratsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72014-06-0132PREAI
Revealing pharmacodynamics of medicinal plants using in silico approach: A case study with wet lab validationCOMPUTERS IN BIOLOGY AND MEDICINEIF6.32014-04-0132PREAI
Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical reviewNATURAL PRODUCT REPORTSIF10.62014-01-0197PREAI
Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodentsPHARMACOLOGY BIOCHEMISTRY AND BEHAVIORIF2.52012-01-0132PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向